Medexus Pharmaceuticals Inc (MDP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,069 | 9,273 | 9,647 | 7,285 | 10,018 |
| Receivables | 22,381 | 20,323 | 17,017 | 14,715 | 14,407 |
| Inventories | 22,848 | 22,404 | 23,758 | 21,979 | 21,351 |
| Other current assets | 2,295 | 1,176 | 1,084 | 1,103 | 1,280 |
| TOTAL | $72,969 | $61,886 | $56,686 | $48,385 | $49,111 |
| Non-Current Assets | |||||
| PPE Net | 899 | 953 | 1,021 | 1,125 | 1,221 |
| Intangibles | 80,655 | 81,896 | 83,157 | 85,338 | 87,251 |
| Other Non-Current Assets | 6,806 | 1,585 | 1,444 | 1,551 | 1,642 |
| TOTAL | $88,360 | $84,434 | $85,622 | $88,014 | $90,114 |
| Total Assets | $161,329 | $146,320 | $142,308 | $136,399 | $139,225 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 42,706 | 65,177 | 29,698 | 19,559 | 15,046 |
| Accounts payable and accrued liabilities | 10,158 | 27,683 | 28,875 | 25,421 | 12,046 |
| Accrued Expenses | 23,257 | N/A | N/A | N/A | 17,128 |
| Other current liabilities | 2,700 | 4,130 | 2,682 | 3,138 | 2,635 |
| TOTAL | $83,496 | $100,806 | $64,752 | $49,703 | $48,108 |
| Non-Current Liabilities | |||||
| Long Term Debt | 27,377 | 484 | 30,871 | 37,948 | 39,816 |
| Other Non-Current Liabilities | 28,008 | 28,095 | 28,301 | 29,815 | 31,988 |
| TOTAL | $55,385 | $30,086 | $60,609 | $69,133 | $73,325 |
| Total Liabilities | $138,881 | $130,892 | $125,361 | $118,836 | $121,433 |
| Shareholders' Equity | |||||
| Common Shares | 69,014 | 68,962 | 68,797 | 68,689 | 68,686 |
| Retained earnings | -64,028 | -70,884 | -69,377 | -66,647 | -65,249 |
| Other shareholders' equity | 6,155 | 6,390 | 6,692 | 4,837 | 3,971 |
| TOTAL | $22,448 | $15,428 | $16,947 | $17,563 | $17,792 |
| Total Liabilities And Equity | $161,329 | $146,320 | $142,308 | $136,399 | $139,225 |